These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4306072)

  • 21. Effectiveness of orally administered Bordetella pertussis vaccine in mice.
    Hof H; Finger H; Körner L; Milcke L
    Dev Biol Stand; 1976; 33():47-53. PubMed ID: 182602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Improved technology of culturing Bordetella pertussis based on a study of the kinetics of the process].
    Miriasova LV; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Oct; (10):20-5. PubMed ID: 6318479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability in derivative strains of Bordetella pertussis.
    Parker CD; Doyle S; Field LH; Hewlett E
    Dev Biol Stand; 1980; 45():119-27. PubMed ID: 6249689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological and histological reactions to respiratory administration of ribosomal Bordetella pertussis vaccine in mice.
    Bartlema HC; Braunius R
    Z Erkr Atmungsorgane; 1979 May; 153(2):254-60. PubMed ID: 232799
    [No Abstract]   [Full Text] [Related]  

  • 25. Considerations on the sensitization properties of Bordetella pertussis.
    Kirchev P; Vesselinova H; Boshkov B; Galabov S
    Nauchni Tr Vissh Med Inst Sofiia; 1969; 48(1):59-63. PubMed ID: 4191303
    [No Abstract]   [Full Text] [Related]  

  • 26. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine production as a unit process.
    van Hemert P
    Prog Ind Microbiol; 1974; 13():151-271. PubMed ID: 4373785
    [No Abstract]   [Full Text] [Related]  

  • 28. [Laboratory diagnosis of pertussis. Role of serology].
    Sanz Moreno JC; De Ory Manchón F; González Alonso J; de La Torre JL; Salmerón F; Limia A; Tello O; Pachón I; Amela C; Vázquez J; de Ory F; Sanz JC;
    Enferm Infecc Microbiol Clin; 2002 May; 20(5):212-8. PubMed ID: 12006259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of Bordetella pertussis on rosette-forming cells present in the peritoneal fluids of mice.
    Fishel CW; Pross SH; Klein TW
    J Reticuloendothel Soc; 1976 Feb; 19(2):97-108. PubMed ID: 177778
    [No Abstract]   [Full Text] [Related]  

  • 31. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y; Sato H
    Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 36. The reactivity of mice after hyperimmunization with Bordetella pertussis.
    David C; Pozsgi N; Andreescu V; Caffé I
    Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):313-8. PubMed ID: 4377531
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of pigs against Bordetella bronchiseptica infection by parenteral vaccination.
    Harris DL; Switzer WP
    Am J Vet Res; 1972 Oct; 33(10):1975-84. PubMed ID: 4342331
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunological and biological properties of B. pertussis and B. parapertussis].
    Kuklińska D; Kopacka B
    Med Dosw Mikrobiol; 1976; 28(2):137-44. PubMed ID: 178966
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of B. pertussis on the antibody production in mice treated during the neonatal period.
    David C; Pozsgi N
    Arch Roum Pathol Exp Microbiol; 1977; 36(3-4):233-46. PubMed ID: 213041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.